David obtained his Bachelor’s degree in Chemistry at the University Complutense of Madrid (UCM). In his final year he moved to Wroclaw, Poland to carry out his final thesis in the design of new 2.1.1 dioxatriphyrins and he specialised in organic chemistry.
After this he continued his education with a Master’s in Organic Chemistry at the UCM where he joined the MedChemLab headed by Mari-Luz López Rodríguez where he worked on the development of chemical probes for the identification of the molecular targets of cannabidiol, where his curiosity about the realm of medicinal chemistry was piqued.
David is joining the UbiCODE programme to pursue his PhD in Huib Ovaa’s laboratory where he will work on the development of chemical tools from small inhibitor targeting key role enzymes to Ubiquitin and ubiquitin-like (SUMO, NEDD4, heterochains) protein derivatives to gain further knowledge about the vast Ubiquitin Proteasome System (UPS). He will also develop assay reagents and better assays to shed light on the molecular features which remain in the dark making use of the expansive expertise of the team.